… of the immune responses elicited by SARS-CoV-2 mRNA vaccines, built on the data from …
mRNA vaccine uptake/biodistribution and the innate immune response to mRNA vaccines are …

… the mRNA-1273 SARS-CoV-2 vaccine encoding a stabilized prefusion spike trimer, S-2P.
Experience with the mRNA platform for other candidate vaccines … clinical vaccine candidate in …

… need for improved mRNA vaccine formulations or the use of other types of vaccines. In
this review, we discuss the advantages and limitations of mRNA vaccines targeting SARS-CoV-2 …

… Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mRNA vaccines are …
vaccinated individuals have raised questions about the durability of immunity after vaccination…

… In conclusion, the SARS-CoV-2 mRNA vaccines were highly … Widespread vaccination can
be expected to have a major … [ 29 , 30 ] While SARS-CoV-2 mRNA vaccines appear to provide …

… However, there remain significant challenges in the development and testing of vaccines as
… of mRNA-based SARS-CoV-2 vaccines and the current status of the mRNA-1273 vaccine. …

… In this study, we show SARS-CoV-2 mRNA vaccine-induced germinal centre B cells are
maintained at or near peak frequencies for at least 12 weeks after secondary immunization. …

… to mRNA-based SARS-CoV-2 vaccination in immunosuppressed patients may be reduced.
This study assessed the response to 2 doses of mRNA-based SARS-CoV-2 vaccine among …

… We conclude that the plasma neutralizing activity elicited by mRNA vaccination or natural …
that are found in emerging variants of SARS-CoV-2. Vaccine-elicited monoclonal antibodies …

… mRNA-1273, an mRNA vaccine that encodes a SARS-CoV-2 spike protein that is stabilized
in the prefusion conformation. Here we show that mRNA-… D614G mutant 2 SARS-CoV-2 as …